The Microbiome in Quiescent Crohn’s Disease With Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan Pathways
2023 · Gastro Hep Advances · 6 citations
https://doi.org/10.1016/j.gastha.2023.11.005
J
Jeffrey Berinstein
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
141
Papers
1.0K
Citations
15
h-index
17
i10-index
Jeffrey Berinstein is an academic researcher from Michigan Medicine. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Clostridium difficile and Clostridium perfringens research. The author has an h-index of 15, co-authored 120 publications.
ORCID: 0000-0001-7631-9665Papers by this author
worksUPADACITINIB AS SECOND- AND THIRD-LINE SALVAGE THERAPY FOR REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS
2024 · Gastroenterology · 4 citations
https://doi.org/10.1053/j.gastro.2023.11.281
Efficacy and Safety of Sphingosine 1-Phosphate Receptor Modulators for Ulcerative Colitis
2024 · Journal of Clinical Gastroenterology · 3 citations
https://doi.org/10.1097/mcg.0000000000002027
Why Symptoms Linger in Quiescent Crohn’s Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways
2024 · Inflammatory Bowel Diseases · 3 citations
https://doi.org/10.1093/ibd/izae238
Disparities in Vaccination Amongst Socially Vulnerable Patients with Inflammatory Bowel Disease
2024 · Digestive Diseases and Sciences · 2 citations
https://doi.org/10.1007/s10620-024-08733-x
USING LONGITUDINAL C-REACTIVE PROTEIN MEASUREMENTS THROUGHOUT HOSPITALIZATION TO ASSESS COLECTOMY RISK IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS
2025 · Gastroenterology · 1 citations
https://doi.org/10.1053/j.gastro.2025.01.179
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat